These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2798939)

  • 1. Time-dependent tumour repopulation factors in linear-quadratic equations--implications for treatment strategies.
    Dale RG
    Radiother Oncol; 1989 Aug; 15(4):371-81. PubMed ID: 2798939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Derivation of the optimum dose per fraction from the linear quadratic model.
    Jones B; Tan LT; Dale RG
    Br J Radiol; 1995 Aug; 68(812):894-902. PubMed ID: 7551788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiobiological assessment of non-standard and novel radiotherapy treatments using the linear-quadratic model.
    Dale RG
    Med Biol Eng Comput; 1993 Jan; 31(1):53-7. PubMed ID: 8326764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal number and sizes of the doses in fractionated radiotherapy according to the LQ model.
    Bruni C; Conte F; Papa F; Sinisgalli C
    Math Med Biol; 2019 Mar; 36(1):1-53. PubMed ID: 29346681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isoeffect relationships for fractionated biologically targeted radiotherapy.
    O'Donoghue JA
    Radiother Oncol; 1990 Nov; 19(3):257-65. PubMed ID: 2281155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of patient variation on standard- and hypo-fractionated radiotherapy of prostate cancer.
    Xiong W; Li J; Ma CM
    Phys Med Biol; 2005 Apr; 50(7):1483-92. PubMed ID: 15798338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic optimization of a linear-quadratic model with incomplete repair and volume-dependent sensitivity and repopulation.
    Wein LM; Cohen JE; Wu JT
    Int J Radiat Oncol Biol Phys; 2000 Jul; 47(4):1073-83. PubMed ID: 10863081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of a large number of clinical studies for breast cancer radiotherapy: estimation of radiobiological parameters for treatment planning.
    Guerrero M; Li XA
    Phys Med Biol; 2003 Oct; 48(20):3307-26. PubMed ID: 14620060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Some implications of linear-quadratic-linear radiation dose-response with regard to hypofractionation.
    Astrahan M
    Med Phys; 2008 Sep; 35(9):4161-72. PubMed ID: 18841869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The application of the linear-quadratic model to fractionated radiotherapy when there is incomplete normal tissue recovery between fractions, and possible implications for treatments involving multiple fractions per day.
    Dale RG
    Br J Radiol; 1986 Sep; 59(705):919-27. PubMed ID: 3756389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The alfa and beta of tumours: a review of parameters of the linear-quadratic model, derived from clinical radiotherapy studies.
    van Leeuwen CM; Oei AL; Crezee J; Bel A; Franken NAP; Stalpers LJA; Kok HP
    Radiat Oncol; 2018 May; 13(1):96. PubMed ID: 29769103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extending the linear-quadratic model for large fraction doses pertinent to stereotactic radiotherapy.
    Guerrero M; Li XA
    Phys Med Biol; 2004 Oct; 49(20):4825-35. PubMed ID: 15566178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The application of the linear-quadratic dose-effect equation to fractionated and protracted radiotherapy.
    Dale RG
    Br J Radiol; 1985 Jun; 58(690):515-28. PubMed ID: 4063711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal radiotherapy for prostate cancer: predictions for conventional external beam, IMRT, and brachytherapy from radiobiologic models.
    King CR; DiPetrillo TA; Wazer DE
    Int J Radiat Oncol Biol Phys; 2000 Jan; 46(1):165-72. PubMed ID: 10656389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumour cell repopulation during fractionated radiotherapy: correlation between flow cytometric and radiobiological data in three murine tumours.
    Begg AC; Hofland I; Kummermehr J
    Eur J Cancer; 1991; 27(5):537-43. PubMed ID: 1828958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of various growth mechanisms of solid tumour growth within the linear-quadratic model for radiotherapy.
    McAneney H; O'Rourke SF
    Phys Med Biol; 2007 Feb; 52(4):1039-54. PubMed ID: 17264369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mathematical models of tumour and normal tissue response.
    Jones B; Dale RG
    Acta Oncol; 1999; 38(7):883-93. PubMed ID: 10606418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the analysis of clonogenic survival data: Statistical alternatives to the linear-quadratic model.
    Unkel S; Belka C; Lauber K
    Radiat Oncol; 2016 Jan; 11():11. PubMed ID: 26822015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of delays in radiotherapy treatment on tumour control.
    Wyatt RM; Beddoe AH; Dale RG
    Phys Med Biol; 2003 Jan; 48(2):139-55. PubMed ID: 12587901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How low is the alpha/beta ratio for prostate cancer?
    Wang JZ; Guerrero M; Li XA
    Int J Radiat Oncol Biol Phys; 2003 Jan; 55(1):194-203. PubMed ID: 12504054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.